Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
AusPAR: Avelumab
Australian Public Assessment Report
Device/Product Name
Bavencio
Active ingredients
Avelumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2016-03575-1-4
Submission Type
New biological entity
Decision
Approved